Installation of a Synchrotron Radiation Beamline Facility at the J. Bennett Johnston, Sr. Center for Advanced Microstructures and Devices for the Science and Engineering Alliance. Phase I and II. Final report of Grant DE FG 05-95ER45549 for September 15, 1995 to December 15, 1998.

2000 ◽  
Author(s):  
Robert Gooden
2002 ◽  
Author(s):  
Thomas Rudowsky ◽  
Marshall Hynes ◽  
Melvin Luter ◽  
Robert Niewoehner ◽  
Page Senn
Keyword(s):  
Phase I ◽  

2005 ◽  
Author(s):  
Alvin J. Banguilan ◽  
John S. Cable ◽  
Charles E. Cantley ◽  
Leslie Raymer ◽  
Victoria Dabir-Banguilan

2021 ◽  
Vol 22 (2) ◽  
pp. 813
Author(s):  
Isabel Fernandes ◽  
Cecília Melo-Alvim ◽  
Raquel Lopes-Brás ◽  
Miguel Esperança-Martins ◽  
Luís Costa

Osteosarcoma (OS) is a rare condition with very poor prognosis in a metastatic setting. Basic research has enabled a better understanding of OS pathogenesis and the discovery of new potential therapeutic targets. Phase I and II clinical trials are already ongoing, with some promising results for these patients. This article reviews OS pathogenesis and new potential therapeutic targets.


Sign in / Sign up

Export Citation Format

Share Document